Viewing Study NCT06315751

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-05-19 @ 6:57 PM
Study NCT ID: NCT06315751
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-05
First Post: 2023-12-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome
Sponsor: Noema Pharma AG
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Tourette Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NOE-105 View